Some common side effects may include mild nausea, vomiting, or digestive discomfort, especially during the initial stages of treatment
Key elements of nutritional priorities to support GLP-1 therapy for obesity (A joint advisory from the American Society for Nutrition, the American College of Lifestyle medicine, the Obesity Medicine Association and the Obesity Society) Did you know WholisticMatters is powered by Standard Process
Pancreatitis history The package insert for semaglutide lists acute pancreatitis as a serious adverse reaction and states the drug should not be initiated in patients with a history of pancreatitis
For general questions, phone support is perfectly fine
Figure 1: Landscape of GLP-1 coverage in Medicaid for weight loss indication "Recent change" is relative to KFFs August 2024 report
Its a natural way to support gut health and improve gut health